Skip to main content
. 2010 Oct 26;60(2):197–206. doi: 10.1007/s00262-010-0927-9

Fig. 5.

Fig. 5

Effector:CTLA4+ Treg ratios post- versus pre-vaccination. a There were no significant differences in effector:CTLA-4+ Treg ratio pre- and post-vaccination among PCa patients enrolled on study (P = 0.894). b There was a statistically significant increase in effector:CTLA-4+ Treg ratio post-vaccination in PCa patients with OS > HPS (P = 0.029). c There was a statistically significant decrease in effector:CTLA-4+ Treg ratio post-vaccination in PCa patients with OS < HPS (P = 0.027)